Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Bioinformatics ; 33(5): 789-790, 2017 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-28011776

RESUMO

Summary: Simultaneous recordings of myocytes contractility and their cytoplasmic calcium concentration allow powerful studies, particularly on heart failure and other cardiac dysfunctions. Such studies require dedicated and expensive experimental devices that are difficult to use. Thus we propose SarConfoCal, the first and only software to simultaneously analyse both cytoplasmic calcium variations (from fluorescence signal) and myocytes contractility (from sarcomere length measurement) on laser scanning confocal microscopy images. SarConfoCal is easy to set up and use, especially by people without programming skills. Availability and implementation: The software is freely distributed under the GNU General Public License. Download and setup instructions are available at http://pccv.univ-tours.fr/ImageJ/SarConfoCal . It is provided as a toolset for ImageJ (the open-source program for image analysis provided by the National Institutes of Health). SarConfoCal has been tested under Windows, Mac and Linux operating systems. Contact: come.pasqualin@univ-tours.fr. Supplementary information: Supplementary data are available at Bioinformatics online.


Assuntos
Cálcio/análise , Microscopia Confocal/métodos , Células Musculares/ultraestrutura , Sarcômeros/ultraestrutura , Software , Animais , Humanos , Células Musculares/química , Sarcômeros/química
2.
Hemoglobin ; 32(1-2): 17-28, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18274979

RESUMO

Cardiac damage caused by iron overload toxicity is the main cause of death in thalassemia patients. Biopsy samples of poorly chelated thalassemia patients who suffered congestive cardiac failure (CCF) show extensive iron deposition in the myocardium. In one patient who survived CCF, a cardiac biopsy was performed during the removal of a thrombus caused by a port-a-cath, which was used for the administration of intravenous (iv) deferoxamine (DFO). Ultrastructural pathology studies of the cardiac biopsy indicated extensive iron deposition in myocytes with accumulation of iron mainly in lysosomes, leading in some cases to their disruption. Damage to other intracellular components of the myocytes and loss of myofibers was also observed. The patient became intolerant to iv and subcutaneous (sc) DFO 2 years after the CCF, and was then treated with deferiprone (L1) for 7 years. Within 1 year of L1 treatment at 75-80 mg/kg/day, serum ferritin levels were reduced to <0.45 mg/L and she became asymptomatic, needing no further drugs for her cardiomyopathy. Lowering the L1 dose to 50-70 mg/kg/day caused an increase in serum ferritin levels. Maintenance of normal iron stores during the last 3 years as detected by cardiac and liver magnetic resonance imaging (MRI) T2 and T2* and normalization of serum ferritin levels (<0.15 mg/L) was observed following L1 therapy at 80-85 mg/kg/day. Deferiprone (>80 mg/kg/day) appears to be effective in the rapid clearance of cardiac iron, in the reversal of iron overload related cardiomyopathy, in the maintenance of normal iron stores and the overall long-term survival of thalassemia patients.


Assuntos
Cardiomiopatias/tratamento farmacológico , Desferroxamina/uso terapêutico , Quelantes de Ferro/uso terapêutico , Sobrecarga de Ferro/tratamento farmacológico , Ferro/metabolismo , Piridonas/uso terapêutico , Talassemia/tratamento farmacológico , Cardiomiopatias/etiologia , Cardiomiopatias/patologia , Terapia por Quelação , Deferiprona , Desferroxamina/administração & dosagem , Feminino , Ferritinas/análise , Ferritinas/sangue , Humanos , Quelantes de Ferro/administração & dosagem , Sobrecarga de Ferro/etiologia , Imageamento por Ressonância Magnética , Microscopia Eletrônica de Transmissão , Pessoa de Meia-Idade , Células Musculares/efeitos dos fármacos , Células Musculares/metabolismo , Células Musculares/ultraestrutura , Miocárdio/patologia , Piridonas/administração & dosagem , Talassemia/complicações , Talassemia/patologia
3.
Poult Sci ; 84(3): 462-6, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15782915

RESUMO

The recovery of broiler chickens experiencing skeletal muscle myopathy caused by a selenium deficiency was compared with control broiler chickens in an age matched study by ultrastructural analysis of the pectoralis major (PM) muscle and examination of the temporal expression of the developmental fast skeletal myosin heavy chain (MyHC) isoforms. Selenium-deficient chicks showing signs of exudative diathesis (ED) were injected subcutaneously with sodium selenite in water and allowed to recover. At 0, 2, 5, 10, 20, and 30 d after selenium injection, a sample of the PM muscle was removed from selenium-deficient and control chicks for analysis. Ultrastructural analysis revealed vacuolization in the PM of selenium-deficient chicks with little or no visible damage to the sarcomere. Relative amounts of chicken ventricular, embryonic, neonatal, and adult fast skeletal MyHC isoforms were determined using chicken fast skeletal MyHC isoform specific monoclonal antibodies. The temporal expression of the developmental MyHC isoforms was similar in all chickens (P > 0.05). There was no expression of chicken ventricular MyHC observed in the PM of either group. These results indicate that chicken fast muscle recovering from exudative diathetic myopathy does not use the same pathways as chicken skeletal fast muscle regenerating from physical or toxic injury in which temporal expression of the MyHC isoforms is initially predominantly ventricular, then predominantly embryonic, neonatal, and finally predominantly adult developmental MyHC isoform.


Assuntos
Músculo Esquelético/química , Doenças Musculares/veterinária , Cadeias Pesadas de Miosina/análise , Doenças das Aves Domésticas/metabolismo , Isoformas de Proteínas/análise , Selênio/deficiência , Animais , Anticorpos Monoclonais/imunologia , Especificidade de Anticorpos , Galinhas , Ensaio de Imunoadsorção Enzimática , Feminino , Imuno-Histoquímica , Microscopia Eletrônica , Células Musculares/ultraestrutura , Músculo Esquelético/ultraestrutura , Doenças Musculares/etiologia , Doenças Musculares/metabolismo , Miofibrilas/ultraestrutura , Vacúolos/ultraestrutura
4.
Int J Biochem Cell Biol ; 36(4): 728-43, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15010335

RESUMO

Several studies have already demonstrated that micro- and milli-calpains (CAPN 1-CAPN 2), calcium-dependent intracellular cysteine-proteases are involved in many biological phenomenon including muscle growth and development. More particularly, recent studies have demonstrated that milli-calpain is implicated in myoblast fusion. Moreover, in primary muscle cells, these proteases do not appear simultaneously throughout muscle cell differentiation. Because micro- and milli-calpains do not have the same intracellular localization, it appears likely that these two calcium-dependent proteases have different biological roles during muscle cell differentiation. The goal of this study is to determine the role of micro-calpain. We therefore, have developed a muscle cell line in which micro-calpain is over-expressed, using the inducible Tet Regulated Expression System. The outcome is observed by following the behavior of different proteins, considered to be potential substrates of the protease. The present study shows important decreases in the expression level of ezrin (68%), vimentin (64%) and caveolin 3 (76%) whereas many other cytoskeletal proteins remain remarkably stable. Concerning the myogenic transcription factors, only the level of myogenin decreased (59%) after the over-expression of micro-calpain. Ultra structural studies have shown that the myofibrils formed near the cell periphery are normally oriented, lying along the longitudinal axis. This regularity is lost progressively towards the cell center where the cytoskeleton presented an increasing disorganization. All these results indicate that micro-calpain is involved in regulation pathway of myogenesis via at least its action on ezrin, vimentin, caveolin 3 and myogenin, a muscle transcription factor.


Assuntos
Calpaína/fisiologia , Células Musculares/metabolismo , Animais , Calpaína/genética , Caveolina 3 , Caveolinas/genética , Caveolinas/metabolismo , Técnicas de Cultura de Células , Diferenciação Celular , Clonagem Molecular , Proteínas do Citoesqueleto , DNA Complementar/genética , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Desmina/genética , Desmina/metabolismo , Doxiciclina/farmacologia , Fibronectinas/genética , Fibronectinas/metabolismo , Regulação da Expressão Gênica , Humanos , Camundongos , Células Musculares/fisiologia , Células Musculares/ultraestrutura , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/ultraestrutura , Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Proteína MyoD/genética , Proteína MyoD/metabolismo , Fator Regulador Miogênico 5 , Fosfoproteínas/genética , Fosfoproteínas/metabolismo , Transativadores/genética , Transativadores/metabolismo , Vimentina/genética , Vimentina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA